Failure of 18Fluorodeoxyglucose Positron Emission Tomography to Detect the High-Grade Transformation of Nodular Lymphocyte Predominant Hodgkin’s Lymphoma

Publisher： Karger

E-ISSN： 1421-9662|129|4|229-231

ISSN： 0001-5792

Source： Acta Haematologica, Vol.129, Iss.4, 2013-01, pp. : 229-231

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Incidence, management, and outcome of high‐grade transformation of nodular lymphocyte predominant hodgkin lymphoma: Long‐term outcomes from a 30‐year experience

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 6, 2015-06 ,pp. : E103-E110

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rituximab plus Ifosfamide, Carboplatin and Etoposide for T-Cell/Histiocyte-Rich B-Cell Lymphoma Arising in Nodular Lymphocyte-Predominant Hodgkin’s Lymphoma

By  

Case Reports in Oncology, Vol. 5, Iss. 2, 2012-08 ,pp. : 413-419

Karger

Access to resources Recommend Favorite

Importance of F18-Fluorodeoxy-D-2-Glucose Positron Emission Tomography (FDG-PET) for Staging and Therapy Control of Hodgkin’s Lymphoma in Childhood and Adolescence – Consequences for the GPOH-HD 2003 Protocol

By  

Oncology Research and Treatment, Vol. 26, Iss. 5, 2003-11 ,pp. : 489-493

Karger

Access to resources Recommend Favorite

Can Rituximab Improve the Outcome of Patients with Nodular Lymphocyte-Predominant Hodgkin's Lymphoma?

By  

Acta Haematologica, Vol. 134, Iss. 3, 2015-05 ,pp. : 187-192

Karger

Access to resources Recommend Favorite

Identifying racial differences in nodular lymphocyte‐predominant Hodgkin lymphoma

By  

CANCER, Vol. 121, Iss. 19, 2015-10 ,pp. : 3387-3389

John Wiley & Sons Inc

Access to resources Recommend Favorite